TROW
47
-6
CVX
43
-3
THC
60
-5
SPG
60
2
ILMN
32
-9
CFG
74
2
ROP
53
-9
AIV
64
4
URI
60
-6
KSS
39
-7
HUM
41
-4
GILD
47
-8
ICE
59
-3
GLW
45
-3
MAR
63
-5
DHI
44
-3
OXY
36
-2
CCI
30
-11
PGR
59
-3
STI
45
26
TROW
47
-6
CVX
43
-3
THC
60
-5
SPG
60
2
ILMN
32
-9
CFG
74
2
ROP
53
-9
AIV
64
4
URI
60
-6
KSS
39
-7
HUM
41
-4
GILD
47
-8
ICE
59
-3
GLW
45
-3
MAR
63
-5
DHI
44
-3
OXY
36
-2
CCI
30
-11
PGR
59
-3
STI
45
26
Financhill
Back

First Trust Commercial Mortg Opports ETF Vs. Neurogene Industry Stock Comparison

Sell
14

CAAA
First Trust Commercial Mortg Opports ETF

Last Price:
20.29
Seasonality Move:
--
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
14
First Trust Commercial Mortg Opports ETF (CAAA) is a Sell

Is First Trust Commercial Mortg Opports ETF a Buy, Sell or Hold?

  • The current First Trust Commercial Mortg Opports ETF [CAAA] share price is $20.21. The Score for CAAA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • CAAA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CAAA Stock Price Chart

What is First Trust Commercial Mortg Opports ETF's stock price today?

  • The First Trust Commercial Mortg Opports ETF share price today is $20.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAAA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CAAA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 38 Sell
Chaikin Money Flow: 3546 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.21 - 20.43) Sell
Bollinger Bands (100): (20.26 - 20.66) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

CAAA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.23 Sell
20-day SMA: 20.27 Sell
50-day SMA: 20.51 Sell
200-day SMA: 0 Buy
8-day EMA: 20.23 Sell
20-day EMA: 20.29 Sell
50-day EMA: 20.4 Sell
200-day EMA: 2.99 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

First Trust Commercial Mortg Opports ETF Earnings Growth & CAAA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

First Trust Commercial Mortg Opports ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):